Company Overview of Boston Therapeutics, Inc.
Boston Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements to address blood sugar management and inflammatory diseases. It produces and sells SUGARDOWN, a non-systemic complex carbohydrate-based dietary food supplement designed to support healthy post-meal blood glucose levels. The company’s lead product candidates include BTI-320, a non-systemic, carbohydrate based compound, which has completed a Phase IIb clinical trial to reduce post-meal elevation of blood glucose levels in Type 2 diabetic patients; and IPOXYN, an injectable anti-necrosis drug candidate ...
1750 Elm Street
Manchester, NH 03104
Founded in 2009
Key Executives for Boston Therapeutics, Inc.
Founder, Chairman, Chief Executive Officer and Treasurer
Total Annual Compensation: $100.0K
Chief Financial Officer, Principal Accounting Officer and Vice President of Strategic Planning & Investor Relations
Total Annual Compensation: $98.4K
Compensation as of Fiscal Year 2014.
Boston Therapeutics, Inc. Key Developments
Boston Therapeutics, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015
May 20 15
Boston Therapeutics, Inc. reported unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of $51,329 compared with $43,827 for the same period last year. Operating loss was $734,873 compared with $1,558,130 for the same period last year. Net loss was $676,287 or $0.02 basic and diluted compared with $1,566,423 or $0.04 basic and diluted for the same period last year. Revenue increase is primarily related to revenue generated through its marketing partnership with Benchworks SD, LLC.
Boston Therapeutics, Inc. announced delayed 10-Q filing
May 15 15
On 05/15/2015, Boston Therapeutics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Boston Therapeutics, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015
Apr 6 15
Boston Therapeutics, Inc. Presents at 2nd Annual Growth Capital Expo, Apr-13-2015 . Venue: Caesars Palace, Las Vegas, Nevada, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 18, 2015
March 13, 2015